Improvement of 'dynamic analgesia' does not decrease atelectasis after thoracotomy
N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé, N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé
Abstract
There is still controversy concerning the beneficial aspects of 'dynamic analgesia' (i.e. pain while coughing or moving) on the reduction of postoperative atelectasis. In this study, we tested the hypothesis that thoracic epidural analgesia (TEA) prevents these abnormalities as opposed to multimodal analgesia with i.v. patient controlled analgesia (i.v. PCA) after thoracotomy. Fifty-four patients undergoing thoracotomy (lung cancer) were randomly assigned to one of the two groups. Clinical respiratory characteristics, arterial blood gas, and pulmonary function tests (forced vital capacity and forced expiratory volume in 1 s) were obtained before surgery and on the next 3 postoperative days. Atelectasis was compared between the two groups by performing computed tomography (CT) scan of the chest at day 3. Postoperative respiratory function and arterial blood gas values were reduced compared with preoperative values (mean (SD) FEV1 day 0: 1.1 (0.3) litre; 1.3 (0.4) litre) but there was no significant difference between groups at any time. PCA and TEA provided a good level of analgesia at rest (VAS day 0: 21 (15/100); 8 (9/100)), but TEA was more effective for analgesia during mobilization (VAS day 0: 52 (3/100); 25 (17/100)). CT scans revealed comparable amounts of atelectasis (expressed as a percentage of total lung volume) in the TEA (7.1 (2.8)%) and in the i.v. PCA group (6.71 (3.2)%). There was no statistical difference in the number of patients presenting with at least one atelectasis of various types (lamellar, plate, segmental, lobar).
Source: PubMed
Próximos ensayos clínicos
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied...Aún no reclutandoHabilidades motoras | Saludable | Función ejecutiva
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCAún no reclutandoCarcinoma anal de células escamosas
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaAún no reclutandoArtritis Reumatoide | Enfermedad articular degenerativa de la rodillaItalia
-
University of Wisconsin, MadisonAlkermes, Inc.Aún no reclutando
-
Virginia Commonwealth UniversityAún no reclutandoEdema cerebral | Necrosis por radiaciónEstados Unidos
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount...Aún no reclutandoKetamina | IRMf | Depresión - Trastorno Depresivo Mayor | rTMS | Depresión resistente al tratamiento (TRD)Estados Unidos
-
Weill Medical College of Cornell UniversityBD2 LLCAún no reclutandoIRMf | Trastorno Bipolar (TB) | rTMS | Depresión bipolar 1Estados Unidos
-
Xentria, Inc.Aún no reclutando
-
Yale UniversityNational Institute of Mental Health (NIMH)Aún no reclutando
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeReclutamientoFeocromocitoma | Feocromocitoma/Paraganglioma | Feocromocitoma Metastásico | Feocromocitoma Maligno | Feocromocitoma y paraganglioma (PPGL)Reino Unido
-
Carl Zeiss Meditec-Dublin CoCeReclutamientoMembrana epirretiniana | Enfermedad de la retina | Degeneración macular seca relacionada con la edad | Anomalía vitreorretiniana | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal Pigment Epithelium (RPE) AtrophyEstados Unidos
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityReclutamientoCLDN18.2 Tumores sólidos positivosPorcelana